News
‘Black Mould’ [Mucormycosis] – the Dark Side of At-home and Self-COVID-19 Treatment
In fact, it’s not just this particular bug that we need to be concerned about. There are other cousins of mucor lurking in our environment, waiting for the perfect storm of a host to take residence in. Ever wonder...
News
‘COVIDASHA’, a technology shot to battle the 2nd wave of the pandemic
CovidAsha, a chatbot platform on the Web, WhatsApp and Telegram, is a unique initiative by conversational automation heavy-weights Engati, and healthcare ecosystem players like Pharmeasy, VMedo, StanPlus and The Better India, with WhatsApp providing the platform.
CovidAsha was born out...
News
Onyx Scientific bolsters manufacturing capabilities with commercial API license
Onyx Scientific, a small molecule API contract development and manufacturing organisation has received a commercial API license for its UK facility.
The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from...
News
Global exclusive as Iceni Diagnostics licences key virus detection IP from University of Warwick
Iceni Diagnostics, a specialist carbohydrate chemistry company based in Norwich, is delighted to announce that it has agreed an exclusive global licence, to integrate key virus detection intellectual property (IP) developed by the University of Warwick, into its commercial...
News
India’s Drug Regulator DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines
India’s top drug regulator exempted foreign-made COVD-19 vaccines from post-approval bridging trials in the country, if they are approved by certain health bodies.
According to the Indian Express, companies such as Pfizer and Cipla have asked for these exemptions during...
News
Cmed Technology adds more capabilities to its encapsia platform and reports increased demand for use in decentralized trials (DCT)
Cmed Technology has announced increased capabilities for encapsia, its advanced enterprise, cloud-based clinical data system, after increased demand for its use in decentralized trials. Encapsia delivers a complete solution to gather and manage multiple live clinical data sources and...
News
Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19
Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, announced that the company submitted an application to the US Food and Drug Administration (FDA) requesting...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read